ARCHIVES

NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients

This article is from The Cancer Letter archive.

Vol. 09 No. 26 | July 1, 1983

Download PDF Visit The Full Archive

Related Articles

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

AACR considering new office in D.C.

July 18, 2003

New Approaches To Improve Diagnoses In Urogenital Cancers Presented At AUA

September 24, 2004

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

NCAB Orders 23 Unfunded Organ Site Grants Paid, Sends Contradictory Messages On Program Revisions

December 3, 1982

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994